80 related articles for article (PubMed ID: 2523588)
21. Living related donor kidney grafts in the cyclosporine era.
MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A; Crocker J; Ogborn M
Transplant Proc; 1989 Apr; 21(2):3364-5. PubMed ID: 2652839
[TBL] [Abstract][Full Text] [Related]
22. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
[No Abstract] [Full Text] [Related]
23. Comparison of clinical response of DR-matched, MLC-compatible cadaver renal allografts and those from HLA-identical related donors.
Conti DJ; Andersen R; Soper WD; Wolf JS
Transplant Proc; 1987 Feb; 19(1 Pt 1):652-4. PubMed ID: 2978928
[No Abstract] [Full Text] [Related]
24. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine.
Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596
[No Abstract] [Full Text] [Related]
25. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
[No Abstract] [Full Text] [Related]
26. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
[No Abstract] [Full Text] [Related]
27. Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy.
Frei D; Keusch G; Hugentobler M; Probst W; Uhlschmid G; Largiadèr F; Binswanger U
Transplant Proc; 1989 Feb; 21(1 Pt 2):1620-2. PubMed ID: 2652527
[No Abstract] [Full Text] [Related]
28. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
[No Abstract] [Full Text] [Related]
29. Renal transplantation: the patient's choice.
Powers AM
Nurs Clin North Am; 1981; 16(3):551-64. PubMed ID: 6458022
[No Abstract] [Full Text] [Related]
30. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
31. Prednisone withdrawal in HLA identical and one haplotype-matched live-related donor and cadaver renal transplant recipients.
Hariharan S; Schroeder TJ; Weiskittel P; Alexander JW; First MR
Kidney Int Suppl; 1993 Oct; 43():S30-5. PubMed ID: 8246366
[TBL] [Abstract][Full Text] [Related]
32. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal.
Flechner SM; Kerman RH; Van Buren CT; Epps L; Kahan BD
Transplantation; 1984 Dec; 38(6):685-91. PubMed ID: 6239415
[TBL] [Abstract][Full Text] [Related]
33. [Pediatric kidney transplantation and living donors--invaluable by virtue of necessity].
Leumann E; Goetschel P; Neuhaus TJ; Ambühl PM; Candinas D
Schweiz Med Wochenschr; 2000 Oct; 130(43):1581-9. PubMed ID: 11100511
[TBL] [Abstract][Full Text] [Related]
34. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
[TBL] [Abstract][Full Text] [Related]
35. Specific immunological tolerance/optimal graft function in the absence of immunosuppressive therapy.
Burrows L; Reisman L; Schanzer H; Kupfer S
Transplant Proc; 1989 Feb; 21(1 Pt 1):369-72. PubMed ID: 2539670
[No Abstract] [Full Text] [Related]
36. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
[No Abstract] [Full Text] [Related]
37. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
[No Abstract] [Full Text] [Related]
38. Methods to prevent rejection of homografts in man: a report on living related kidney donor selection by HL-A genotyping.
Stickel DL; Seigler HF; Ward FE
Am Surg; 1970 Feb; 36(2):109-15. PubMed ID: 4904925
[No Abstract] [Full Text] [Related]
39. The influence of HLA-D matching on the outcome of intrafamilial kidney transplantation with special emphasis on the predictive value of the relative response in MLC.
Berg B; Groth CG; Lundgren G; Magnusson G; Möller E; Ringdén O
Scand J Urol Nephrol Suppl; 1981; 64():46-51. PubMed ID: 6216584
[TBL] [Abstract][Full Text] [Related]
40. Current results with triple therapy for heart transplantation.
Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B
Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
